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Introduc)on	  
Rapid tumor imaging is essential in the early detection, patient 
classification, and determining treatment effectiveness for 
tumors. One aim of the Hackel Lab is to identify an optimal 
balance between rapid clearance from background tissue and 
the extent of tumor targeting. Albumin is a protein with a 
relatively long half-life compared to other proteins within the 
body, leading to the hypothesis that if a protein binds to the 
albumin it will stay in the body for a slightly longer, yet still 
brief, period of time before being cleared from the 
bloodstream, which would allow for better imaging.   
•  The EGFR target-binding protein clone D fibronectin with 
albumin-binding peptides (DABP, or ABP) identified 
though DNA sequencing as candidate of interest for 
albumin-binding experimentation. 
•  Overall goal: produce 0.5 -1.0 mg of ABP clones for in vivo 
trials on mice. 
  
 
Materials	  and	  methods  
 
Three variations of DABP were compared: high affinity (H), low affinity (L), 
and no affinity (X) for albumin binding. Proteins were created through DNA 
encoding the proteins of interest that were transformed in to E. coli.  Cells 
were cultured in lysogeny broth (LB) to extract the desired protein at large (1 
L) and small-scale (100 mL) levels. The cultures were induced for a varying 
amount of time and at different temperatures to determine the optimal 
conditions for ABP protein production.  
Production lysate was purified using the protein’s characteristic tag of six 
histidines (His6) to bind to nickel spin or cobalt gravity columns . Washes and 
elutions were completed with imidazole at varying concentrations to isolate 
only ABP.  
 
Measurements of A280 predicted the amount of ABP from the production.  
High A280 measurement elutions were further purified with high-pressure 
liquid chromatography(HPLC).  Purified protein identity was confirmed 
through SDS-PAGE and mass spectrometer (MALDI) data.  Correctly 
verified ABP proteins were lyophilized and resuspended in DMSO to be 
conjugated with near infrared fluorophore for in vivo detection.   
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Production data for the clones DABPH, X, and L in the form 
of post-HPLC A280 measurements, HPCL area under the 
curve calculations, and post-lyophilization A280 
measurements were analyzed.  After preliminary productions 
of the clones, the high affinity clone had produced enough to 
move on to the next stage of experimentation- fluorophore 
conjugation- while low and no affinity clones produced 
poorly.  
 
The fluorophore Dylight-800 was attempted to be 
conjugated to the collected sample of DABPH. To determine 
if the conjugation was successful the sample was analyzed 
via mass spectrometer. Complete fluorophore conjugation 
was not evident based on molecular weight analysis. The 
next step would have been to add more fluorophore and 
repeat the process until conjugation was ensured, and the 
protein would be prepped for use in in vivo mice trials. This 
course of action was put on hold until low and no affinity 
binders could definitively be produced for controls. 
 
To increase protein production yields DABPH production 
characteristics were varied.  An induction time of 0.5 hours 
at 37 degrees Celsius was determined to be optimal, and yet 
production yields of DABPX and L were low. Small scale 
productions of these clones were performed to determine if 
this would vary the amount produced, and HPLC area under 
the curve values increased.  This introduced the question of 
whether purification via spin or gravity column had better 
protein yields. Initially a larger area under the curve for 
HPLC plots of spin-purified proteins lent to the conclusion 
that spin purification would yield much higher amounts, but 
upon SDS-Page analysis it was shown that the readings were 
a false positive caused by a contaminant (affibody protein). 
Spin and gravity columns were concluded to purify with 
approximately equivalent effectiveness. 
 
Based on the inability to produce high yields of low- and no-
binding affinity to albumin clones, the decision was made to 
halt work on the experiment.  DABP production ceased, and 
DABPH fluorophore conjugation was not revisited in the 
mindset to save time and materials from being wasted on an 
objective that is essentially unattainable through the 
proposed mechanism.  
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Purifica)on	  Comparison 
Figure 1 Representative HPLC Plot:  !
High pressure liquid chromatography plot for a sample of DABPH, shown in Arbitrary Units 
vs. time (min). The area under the curve can be related mathematically to the amount of 
protein present in a sample; larger area indicates more protein. HPLC area under the curve 
calculations along with A280 measurements provided the greatest insight to the amount of 
protein present in a purified sample.!
Figure 2 Mass Spectrometry Data Post-Fluorophore Conjugation:  !
A mass spectrometry print-out of a reading done on DABPH post-attempted 
fluorophore (Dylight-800) conjugation.  The numbers shown on the x-axis, along with 
those above the peaks are molecular weights (g/mol). The above reading shows that 
the fluorophore may not have completely conjugated; DABPH has a molecular weight 
of 12605 g/mol (first peak), and a large peak at a molecular weight of approximately 
13655 g/mol is expected if the Dylight-800 conjugated to the protein. !
Figure 3 Purification 
Comparison HPLC Plots 
(left):!
High pressure liquid 
chromatography plots for a 
purified protein, split into two 
samples- one sample purified 
via spin column (Bottom) and 
the other via drip column 
(Top). The initial large peak is 
a solvent shift, and has no 
importance and no effect on 
the data. !
Figure 4 SDS-Page Verification of Comparison 
Protein Purity!
SDS-Page uses electrophoresis to separate DNA based on 
weight. Lanes 1 and 2 are spin column samples, Lane 3 is a 
gravity column sample, Lane 4 is the ladder for comparison; 
Lanes that are unlabeled are unrelated proteins. The bright lines 
at the bottom of lanes 1 and 2 indicate contaminant present. !
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